Inventor · disambiguated record
Mette Dahl Andersen
Also filed as: ANDERSEN METTE D · ANDERSEN METTE DAHL
7 granted patents·13 pending applications·54 citations·filing 2001–2024
81Inventor score
Top patents by PatentIndex Score
20 records- 0195US8981061B2Receptor TREM (triggering receptor expressed on myeloid cells) and uses thereofNOVO NORDISK AS·Filed 2012·Granted Mar 17, 2015·41 cites·2 claims
- 0285US9926373B2Human CD30 ligand antigen binding proteinsNOVO NORDISK AS·Filed 2013·Granted Mar 27, 2018·10 cites·6 claims
- 0383US2025289898A1Human cd30 ligand antigen binding proteinsNOVO NORDISK AS·Filed 2024·Application pending·0 cites
- 0473US9737612B2Antagonistic DR3 ligandsANDERSEN METTE DAHL·Filed 2012·Granted Aug 22, 2017·3 cites·17 claims
- 0570US2022112295A1Human cd30 ligand antigen binding proteinsAMGEN INC·Filed 2021·Application pending·0 cites
- 0659US10106606B2Targeting tissue factor to activated plateletsNOVO NORDISK AS·Filed 2016·Granted Oct 23, 2018·0 cites·12 claims
- 0759US9713644B2Antagonistic DR3 ligandsNOVO NORDISK AS·Filed 2014·Granted Jul 25, 2017·0 cites·27 claims
- 0859US2019062429A1Targeting tissue factor to activated plateletsNOVO NORDISK AS·Filed 2018·Application pending·0 cites
- 0957US8765130B2Antagonistic DR3 ligandsNOVO NORDISK AS·Filed 2013·Granted Jul 1, 2014·0 cites·23 claims
- 1056US2017320946A1Receptor trem (triggering receptor expressed on myeloid cells) and uses thereofNOVO NORDISK AS·Filed 2017·Application pending·0 cites
- 1154US2018298105A1Human CD30 Ligand Antigen Binding ProteinsNOVO NORDISK AS·Filed 2018·Application pending·0 cites
- 1253US2017305994A1Antagonistic DR3 LigandsNOVO NORDISK AS·Filed 2017·Application pending·0 cites
- 1351US2016251434A1Novel receptor trem (triggering receptor expressed on myeloid cells) and uses thereofNOVO NORDISK AS·Filed 2015·Application pending·0 cites
- 1447US2012178908A1Targeting tissue factor to activated plateletsHILDEN IDA·Filed 2010·Application pending·0 cites
- 1539US2016297892A1Novel Methods and Antibodies for Treating CoagulapathyNOVO NORDISK AS·Filed 2014·Application pending·0 cites
- 1638US9080200B2Method of quality control testing a Factor XIII containing sampleANDERSEN METTE DAHL·Filed 2009·Granted Jul 14, 2015·0 cites·13 claims
- 1738US2003166202A1P450 Monooxygenases of the cyp79 familyFiled 2001·Application pending·0 cites
- 1837US2014065154A1Tlr3 binding agentsGAUTHIER LAURENT·Filed 2012·Application pending·0 cites
- 1936US2013323259A1Il-21 ligandsSVENSSON LARS ANDERS·Filed 2012·Application pending·0 cites
- 2035US2014170153A1Il-21 epitope and il-21 ligandsSVENSSON ANDERS·Filed 2012·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Mette Dahl Andersen files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →